Transforming Management of Opioid Use Disorder with Universal Treatment

Barriers at multiple levels impede the use of evidence-based medication for opioid use disorder. Actions by clinicians, health care systems, and policymakers could substantially expand treatment access.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 387; no. 15; pp. 1341 - 1344
Main Authors Gupta, Rahul, Levine, Rachel L., Cepeda, Javier A., Holtgrave, David R.
Format Journal Article
LanguageEnglish
Published Boston Massachusetts Medical Society 13.10.2022
Subjects
Addiction
Addictions
and Education
and Education General
and the FDA
Clinical Medicine
Devices
Drug abuse
Drug addiction
Drug overdose
Drug use
Drug withdrawal
Drugs
Emergency medical care
Emergency Medicine
Emergency Medicine General
Health care
Health care industry
Health Policy
Health services
Hepatitis C
HIV
Human immunodeficiency virus
Imprisonment
Infrastructure
Medical education
Medical Practice
Mental disorders
Mental health care
Methadone
Mortality
Narcotics
Opioids
Outpatient-Based Clinical Medicine
Pandemics
Patients
Psychiatry
Public Health
Public Health General
Stigma
Substance abuse treatment
Substance use disorder
Telemedicine
Training
Transportation services
Waivers
United States > US
Public Health
Medical Practice
Drug and Device Safety
Health Policy
Online AccessGet full text

Cover

More Information
Summary:Barriers at multiple levels impede the use of evidence-based medication for opioid use disorder. Actions by clinicians, health care systems, and policymakers could substantially expand treatment access.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMp2210121